Daily News Podcast

Lorcaserin shows cardiovascular safety

Publish date: August 27, 2018

 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Mobile contraception app gets FDA approval
MDedge Infectious Disease
French warn of upsurge in pneumococcal meningitis
MDedge Infectious Disease
Variation doesn’t mean quality when it comes to diet
MDedge Infectious Disease
Medicare Advantage pushback
MDedge Infectious Disease
Psoriasis registry study provides more data on infliximab’s infection risk
MDedge Infectious Disease
Open AAA and peripheral bypass surgery patients among the highest users of post-acute care
MDedge Infectious Disease
Sleepio app tied to reducing insomnia, depression
MDedge Infectious Disease
5 digital HIPAA myths
MDedge Infectious Disease
Screen for cervical cancer based on age, risk
MDedge Infectious Disease
Is it time for PCPs to take over chronic HCV?
MDedge Infectious Disease